Compound Summary
Compound Name: | 			(-)-alpha-Methylnorepinephrine | 
Compound CID: | 			11957514 | 
Synonyms: | 			(-)-alpha-Methylnorepinephrine Lopac0_000359 SCHEMBL6295856 CHEMBL1320902 HMS3261G19 More... | 
Iupac Name: | 			4-[(1R)-2-amino-1-hydroxypropyl]benzene-1,2-diol | 
InChI: | 					InChI=1S/C9H13NO3/c1-5(10)9(13)6-2-3-7(11)8(12)4-6/h2-5,9,11-13H,10H2,1H3/t5?,9-/m0/s1 | 
InChIKey: | 				GEFQWZLICWMTKF-YQFNKJDISA-N | 
Canonical Smiles: | 		CC(C(C1=CC(=C(C=C1)O)O)O)N | 
Isomeric Smiles: | 			CC([C@@H](C1=CC(=C(C=C1)O)O)O)N | 
Molecular Weight: | 		183.2 | 
Molecular Formula: | 			C9H13NO3 | 
Molecular Weight: | 		183.2 | 
Molecular Formula: | 			C9H13NO3 | 
Hydrogen Bond Donor Count: | 			4 | 
Hydrogen Bond Acceptor Count: | 			4 | 
Rotatable Bond Count: | 			2 | 
Heavy Atom Count: | 					13 | 
Complexity: | 				165 | 
| (-)-alpha-Methylnorepinephrine | (-)-alpha-Methylnorepinephrine | 
|---|---|
(-)-alpha-Methylnorepinephrine | 			
Lopac0_000359 | 
SCHEMBL6295856 | 			
CHEMBL1320902 | 
HMS3261G19 | 			
Tox21_500359 | 
PDSP1_001112 | 			
PDSP2_001096 | 
CCG-204454 | 			
LP00359 | 
SDCCGSBI-0050347.P002 | 			
NCGC00093795-01 | 
NCGC00093795-02 | 			
NCGC00093795-03 | 
NCGC00093795-04 | 			
NCGC00093795-05 | 
NCGC00093795-06 | 			
NCGC00261044-01 | 
EU-0100359 | 			
Levonordefrin; (-)-3,4-Dihydroxynorephedrine | 
D 5290 | 			
SR-01000075277 | 
SR-01000075277-1 | 			
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | -3.000000000000000 | NS | N2 | 24134630 | Inactive | 
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point | 
|---|---|---|---|---|
| Caenorhabditis elegans | -3.000000000000000 | 1 | 1 |